During the recent session, Harrow Inc (NASDAQ:HROW)’s traded shares were 0.59 million, with the beta value of the company hitting 0.43. At the last check today, the stock’s price was $28.33, reflecting an intraday gain of 1.65% or $0.46. The 52-week high for the HROW share is $59.23, that puts it down -109.07 from that peak though still a striking 65.2% gain since the share price plummeted to a 52-week low of $9.86. The company’s market capitalization is $1.01B, and the average intraday trading volume over the past 10 days was 0.79 million shares, and the average trade volume was 425.81K shares over the past three months.
Harrow Inc (HROW) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. HROW has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.12.
Harrow Inc (NASDAQ:HROW) trade information
Harrow Inc (HROW) registered a 1.65% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.65% in intraday trading to $28.33, hitting a weekly high. The stock’s 5-day price performance is -0.28%, and it has moved by 2.79% in 30 days. Based on these gigs, the overall price performance for the year is 125.20%. The short interest in Harrow Inc (NASDAQ:HROW) is 2.92 million shares and it means that shorts have 7.64 day(s) to cover.
The consensus price target of analysts on Wall Street is $64, which implies an increase of 55.73% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $55 and $73 respectively. As a result, HROW is trading at a discount of -157.68% off the target high and -94.14% off the low.
Harrow Inc (HROW) estimates and forecasts
In the rating firms’ projections, revenue will increase 42.31% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 61.13M as predicted by 4 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 69.68M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 34.59M and 48.94M respectively. In this case, analysts expect current quarter sales to grow by 76.74% and then jump by 42.39% in the coming quarter.
HROW Dividends
Harrow Inc is due to release its next quarterly earnings on 2025-Mar-26. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Harrow Inc (NASDAQ:HROW)’s Major holders
Harrow Inc insiders own 13.49% of total outstanding shares while institutional holders control 59.11%, with the float percentage being 68.32%. OPALEYE MANAGEMENT INC. is the largest shareholder of the company, while 226.0 institutions own stock in it. As of 2024-06-30, the company held over 3.99 million shares (or 11.2019% of all shares), a total value of $83.35 million in shares.
The next largest institutional holding, with 2.71 million shares, is of PRIVATE CAPITAL MANAGEMENT, LLC’s that is approximately 7.6219% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $56.71 million.
Also, the Mutual Funds coming in first place with the largest holdings of Harrow Inc (HROW) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 978.49 shares. This amounts to just over 2.75 percent of the company’s overall shares, with a $27.34 million market value. The same data shows that the other fund manager holds slightly less at 788.29, or about 2.21% of the stock, which is worth about $22.02 million.
